Rocket Lab USA Inc.Stock fell 6.6% as SpaceX IPO drew investor attention; negative EBITDA and high P/S ratio highlight financial concerns
Rocket Lab shares fell about 6.6% from the day before SpaceX began trading on June 12, even as SpaceX stock surged past $200. Rocket Lab’s trailing twelve-month revenue reached $679.6 million, but it posted negative EBITDA of $140.1 million and holds $1 billion in cash against a $67 billion market cap. The company’s Neutron rocket, scheduled to launch by year-end after multiple delays, is seen as key to unlocking heavier payload contracts and competing with SpaceX’s Falcon 9. Rocket Lab trades at a price-to-sales ratio of 100, compared to SpaceX’s 130 times sales, and may have more room to grow into its valuation for risk-tolerant investors with a long horizon.
Rocket Lab USA Inc.Stock fell 6.6% as SpaceX IPO drew investor attention; negative EBITDA and high P/S ratio highlight financial concerns
Space Exploration Technologies Corp. Class A Common StockSpaceX stock surged past $200 on its first trading day, reflecting strong investor demand for the IPO.
NVIDIA Corporation